Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Modality Detection of RCC Recurrence Post Ablation

NCT05641935 is registered in ClinicalTrials.gov with john eisenbrey as lead sponsor.

NCT NCT05641935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05641935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Modality Detection of RCC Recurrence Post Ablation
Lead sponsor
john eisenbrey
Phase
Phase 2
Overall status
Recruiting
Start date
November 3, 2022
Completion date
August 31, 2027
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent renal cell carcinoma, renal cell carcinoma